SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Experimental and Clinical Transplantation, 2014, 12, Suppl 1

    CrossRef

  2. 2
    Sam M. Mbulaiteye, Christina A. Clarke, Lindsay M. Morton, Todd M. Gibson, Karen Pawlish, Dennis D. Weisenburger, Charles F. Lynch, Marc T. Goodman, Eric A. Engels, Burkitt lymphoma risk in U.S. solid organ transplant recipients, American Journal of Hematology, 2013, 88, 4
  3. 3
    H. Zimmermann, R. U. Trappe, EBV and posttransplantation lymphoproliferative disease: what to do?, Hematology, 2013, 2013, 1, 95

    CrossRef

  4. 4
    Zeina Al-Mansour, Beverly P. Nelson, Andrew M. Evens, Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies, Current Hematologic Malignancy Reports, 2013, 8, 3, 173

    CrossRef

  5. 5
    Martin Mynarek, Tilmann Schober, Uta Behrends, Britta Maecker-Kolhoff, Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  6. 6
    Immunosuppressants, Reactions Weekly, 2012, 1431, 1, 25

    CrossRef

  7. 7
    Denis Glotz, Jeremy R. Chapman, Vikas R. Dharnidharka, Douglas W. Hanto, Maria C.R. Castro, Hans H. Hirsch, Véronique Leblond, Aneesh K. Mehta, Bruno Moulin, Antonio Pagliuca, Julio Pascual, Alan B. Rickinson, Francesco P. Russo, Ralf U. Trappe, Angela C. Webster, Andreas O. Zuckermann, Thomas G. Gross, The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders, Transplantation Journal, 2012, 94, 8, 784

    CrossRef

  8. 8
    Michael Green, Steven A. Webber, Post-Transplant Lymphoproliferative Disorders,